Antineoplaston AS2-1 oral
Alternative Names: Fengenal®Latest Information Update: 25 Sep 2021
At a glance
- Originator Burzynski Research Institute
- Class Amino acids; Antineoplastons; Phenylacetates
- Mechanism of Action Apoptosis stimulants; Cell cycle inhibitors; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Brain cancer; Cancer metastases